---
title: "Cimetidine - Zollinger-Ellison Syndrome"
sidebar: mydoc_sidebar
permalink: db00501-mesh-d015043-1.html
toc: false 
---


Path ID: `DB00501_MESH_D015043_1`
{% include image.html url="images/db00501-mesh-d015043-1.png" file="db00501-mesh-d015043-1.png" alt="db00501-mesh-d015043-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D002927 | Cimetidine | Drug |
| UniProt:P25021 | Histamine H2 receptor | Protein |
| GO:0034776 | Response to histamine | BiologicalProcess |
| InterPro:IPR000072 | Vascular endothelial growth factor (VEGF) | GeneFamily |
| MESH:D015043 | Zollinger-Ellison syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Cimetidine | DECREASES ACTIVITY OF | Histamine H2 Receptor |
| Histamine H2 Receptor | PREVENTS | Response To Histamine |
| Response To Histamine | NEGATIVELY REGULATES | Vascular Endothelial Growth Factor (Vegf) |
| Vascular Endothelial Growth Factor (Vegf) | CORRELATED WITH | Zollinger-Ellison Syndrome |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00501#mechanismofaction](https://go.drugbank.com/drugs/DB00501#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology](https://pubchem.ncbi.nlm.nih.gov/compound/Cimetidine#section=Pharmacology)
